The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
Open accessAbstract
Soon after they were first described in 1990, aptamers were largely recognized as a new class of biological ligands that can rival antibodies in various analytical, diagnostic, and therapeutic applications. Aptamers are short single-stranded RNA or DNA oligonucleotides capable of folding into complex 3D structures, enabling them to bind to a large variety of targets ranging from small ions to an entire organism. Their high binding specificity and affinity make them comparable to antibodies, but they are superior regarding a longer shelf life, simple production and chemical modification, in addition to low toxicity and immunogenicity. In the past three decades, aptamers have been used in a plethora of therapeutics and drug delivery systems that involve innovative delivery mechanisms and carrying various types of drug cargos. However, the successful translation of aptamer research from bench to bedside has been challenged by several limitations that slow down the realization of promising aptamer applications as therapeutics at the clinical level. The main limitations include the susceptibility to degradation by nucleases, fast renal clearance, low thermal stability, and the limited functional group diversity. The solution to overcome such limitations lies in the chemistry of aptamers. The current review will focus on the recent arts of aptamer chemistry that have been evolved to refine the pharmacological properties of aptamers. Moreover, this review will analyze the advantages and disadvantages of such chemical modifications and how they impact the pharmacological properties of aptamers. Finally, this review will summarize the conjugation strategies of aptamers to nanocarriers for developing targeted drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–251 of 251
Potential Capacity of Aptamers to Trigger Immune Activation in Human Blood
Avci‐Adali, M., Steinle, H., Michel, T., Schlensak, C., & Wendel, H. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068810 · Cited by 59
Lee, K. Y., Kang, H., Ryu, S. H., et al. (2010) · BioMed Research International · doi:10.1155/2010/168306 · Cited by 57
Ohsawa, K., Kasamatsu, T., Nagashima, J.-I., Hanawa, K., Kuwahara, M., Ozaki, H., & Sawai, H. (2008) · Analytical Sciences · doi:10.2116/analsci.24.167 · Cited by 57
Hollenstein, M. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201201662 · Cited by 57
Vater, A., Sell, S., Kaczmarek, P., Maasch, C., Buchner, K., Pruszyńska‐Oszmałek, E., Kolodziejski, P. A., Purschke, W. G., Nowak, K. W., Strowski, M. Z., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444414 · Cited by 56
Esfandyari‐Manesh, M., Mohammadi, A., Atyabi, F., Nabavi, S. M., Ebrahimi, S. M., Shahmoradi, E., Varnamkhasti, B. S., Ghahremani, M. H., & Dinarvand, R. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.066 · Cited by 55
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Aravind, A., Varghese, S. H., Veeranarayanan, S., Mathew, A., Nagaoka, Y., Iwai, S., Fukuda, T., Hasumura, T., Yoshida, Y., Maekawa, T., et al. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-011-0024-6 · Cited by 53
Haruta, K., Otaki, N., Nagamine, M., Kayo, T., Sasaki, A., Hiramoto, S., Takahashi, M., Hota, K., Sato, H., & Yamazaki, H. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0627 · Cited by 53
Aptamer-Modified Temperature-Sensitive Liposomal Contrast Agent for Magnetic Resonance Imaging
Zhang, K., Liu, M., Tong, X., Sun, N., Zhou, L., Cao, Y., Wang, J., Zhang, H., & Pei, R. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00250 · Cited by 52
RNA Aptamers and Spiegelmers: Synthesis, Purification, and Post‐Synthetic PEG Conjugation
Hoffmann, S., Hoos, J. S., Klußmann, S., & Vonhoff, S. (2011) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0446s46 · Cited by 52
Efficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase
Veedu, R. N., Vester, B., & Wengel, J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b819946a · Cited by 52
Somasunderam, A., Ferguson, M. R., Rojo, D. R., Thiviyanathan, V., Li, X., O’Brien, W. A., & Gorenstein, D. G. (2005) · Biochemistry · doi:10.1021/bi0507074 · Cited by 52
Song, X., Ren, Y., Zhang, J., WANG, G., Han, X., ZHENG, W., & Zhen, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4136 · Cited by 52
Lauridsen, L. H., Rothnagel, J. A., & Veedu, R. N. (2011) · ChemBioChem · doi:10.1002/cbic.201100648 · Cited by 52
Zeng, Y.-B., Yu, Z., He, Y., Zhang, T., Du, L., Dong, Y., Chen, H., Zhang, Y., & Wang, W. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.166 · Cited by 52
Therapeutic aptamers in discovery, preclinical and clinical stages
Ismail, S. I., & Alshaer, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.006 · Cited by 52
Self-citationRiccardi, C., Fàbrega, C., Grijalvo, S., Vitiello, G., D’Errico, G., Eritja, R., & Montesarchio, D. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01563e · Cited by 50
Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
Haßel, S. K., & Mayer, G. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00400-6 · Cited by 49
Zhou, C., Chen, T., Wu, C. S., Zhu, G., Qiu, L., Cui, C., Hou, W., & Tan, W. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201403115 · Cited by 48
Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer
Kurosaki, T., Higuchi, N., Kawakami, S., Higuchi, Y., Nakamura, T., Kitahara, T., Hashida, M., & Sasaki, H. (2011) · Gene · doi:10.1016/j.gene.2011.09.021 · Cited by 47
Shoyele, S., Maher, C. M., Lakshmikuttyamma, A., & Perepelyuk, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110488 · Cited by 47
Riccardi, C., Musumeci, D., Krauss, I. R., Piccolo, M., Irace, C., Paduano, L., & Montesarchio, D. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.06.137 · Cited by 47
Li, X., Zhu, X., & Qiu, L. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.012 · Cited by 45
Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
Jurek, P., Zabłocki, K., Wasko, U. N., Mazurek, M., Otlewski, J., & Jeleń, F. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125231 · Cited by 44
Yu, Z., Chen, F., Qi, X., Dong, Y., Zhang, Y., Ge, Z., Cai, G., & Zhang, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5578 · Cited by 43
Aptamer-guided acridine derivatives for cervical cancer
Carvalho, J., Lopes‐Nunes, J., Lopes, A. C. B., Campello, M. P. C., Paulo, A., Queiroz, J. A., & Cruz, C. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00318e · Cited by 42
Tumor cell-specific photothermal killing by SELEX-derived DNA aptamer-targeted gold nanorods
Chandrasekaran, R., Lee, A. S. W., Yap, L. W., Jans, D. A., Wagstaff, K. M., & Cheng, W. (2015) · Nanoscale · doi:10.1039/c5nr07831h · Cited by 41
Whole cell-SELEX of aptamers with a tyrosine-like side chain against live bacteria.
Renders, M., Miller, E., Lam, C. H., & Perrin, D. (2017) · Organic and biomolecular chemistry · doi:10.1039/c6ob02451c · Cited by 41
Structural Basis for Expansion of the Genetic Alphabet with an Artificial Nucleobase Pair
Betz, K., Kimoto, M., Diederichs, K., Hirao, I., & Marx, A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704190 · Cited by 38
Duo, J., Chiriac, C., Huang, R. Y. ‐., Mehl, J. T., Chen, G., Tymiak, A. A., Sabbatini, P., Pillutla, R. C., & Zhang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05277 · Cited by 37
Fan, T., Gu, M., Li, K., Zhang, L.-X., Wang, H., Liu, L.-S., Zheng, Z., Han, N.-Y., & Yang, Z. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84351 · Cited by 36
X-Aptamer Selection and Validation
Lokesh, G. L.-R., Wang, H., Lam, C. H., Thiviyanathan, V., Ward, N. E., Gorenstein, D. G., & Volk, D. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7138-1_10 · Cited by 36
An l ‐RNA Aptamer with Expanded Chemical Functionality that Inhibits MicroRNA Biogenesis
Kabza, A. M., & Sczepanski, J. T. (2017) · ChemBioChem · doi:10.1002/cbic.201700362 · Cited by 34
Fan, W., Wang, X., Ding, B., Cai, H., Wang, X., Fan, Y., Li, Y., Liu, S., Nie, S., & Lu, Q. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1077850 · Cited by 33
Dong, H., Han, L., Wang, J., Xie, J., Gao, Y., Xie, F., & Jia, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.004 · Cited by 32
Pharmacokinetic Properties of DNA Aptamers with Base Modifications
Gupta, S., Drolet, D. W., Wolk, S. K., Waugh, S. M., Rohloff, J. C., Carter, J. D., Mayfield, W. S., Otis, M. R., Fowler, C. R., Suzuki, T. W., et al. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0683 · Cited by 31
Batool, S., Argyropoulos, K. V., Azad, R., Okeoma, P., Zümrüt, H. E., Bhandari, S., Dekhang, R., & Mallikaratchy, P. R. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.10.006 · Cited by 31
Svobodová, M., Bunka, D. H. J., Nadal, P., Stockley, P. G., & O’Sullivan, C. K. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7350-y · Cited by 30
Thioaptamers targeting dengue virus type-2 envelope protein domain III
Gandham, S. H. A., Volk, D. E., Lokesh, G. L.-R., Neerathilingam, M., & Gorenstein, D. G. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.053 · Cited by 28
A Temperature-Responsive Antibody-Like Nanostructure
Zhou, J., Soontornworajit, B., & Wang, Y. (2010) · Biomacromolecules · doi:10.1021/bm100450k · Cited by 27
Selecting Fully‐Modified XNA Aptamers Using Synthetic Genetics
Taylor, A. I., & Holliger, P. (2018) · Current Protocols in Chemical Biology · doi:10.1002/cpch.44 · Cited by 26
In Vivo SELEX of Single-Stranded Domains in the HIV-1 Leader RNA
van Bel, N., Das, A. T., & Berkhout, B. (2013) · Journal of Virology · doi:10.1128/jvi.02942-13 · Cited by 23
Leonard, F., Ha, N. P., Sule, P., Alexander, J. F., Volk, D. E., Lokesh, G. L.-R., Liu, X., Cirillo, J. D., Gorenstein, D. G., Yuan, J., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.038 · Cited by 20
Goebl, N. A., Berridge, B. R., Wroblewski, V. J., & Brown‐Augsburger, P. (2007) · Toxicologic Pathology · doi:10.1080/01926230701338958 · Cited by 19
Guo, F., Hu, Y. W., Yu, L., Deng, X., Meng, J., Wang, C., & Yang, X. (2016) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2016.10941 · Cited by 19
Wilbanks, B. A., Smestad, J. A., Heider, R. M., Warrington, A. E., Rodriguez, M., & Maher, L. J., III (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0776 · Cited by 19
Wang, Y., Ng, N., Liu, E., Lam, C. H., & Perrin, D. M. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob02335e · Cited by 17
Kang, Y. Y., Song, J., Jung, H. S., Kwak, G., Yu, G., Ahn, J., Kim, S. H., & Mok, H. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.11.011 · Cited by 14
Xu, C., Han, X., Jiang, Y., Yuan, S., Wu, Z., Wu, Z., & Qi, X. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00324 · Cited by 7
DNA-conjugated gold nanoparticles for ultrasound targeted drug delivery
Kang, S., Luo, Y.-L., Huang, Y., & Yeh, C. (2012) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2012.0468 · Cited by 5
Aptamer-Based Strategies for Diagnostics
Rodriguez, P. E. D. S., & Nash, V. I. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00006-x · Cited by 5
Cited by
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Self-citationsiRNA: Mechanism of action, challenges, and therapeutic approaches
Alshaer, W., Zureigat, H., Al Karaki, A., Al-Kadash, A., Gharaibeh, L., Hatmal, M. M., Aljabali, A. A. A., & Awidi, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174178 · Cited by 441
Self-citationDetection and beyond: challenges and advances in aptamer-based biosensors
Yoo, H., Jo, H., & Oh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00639d · Cited by 334
Recent progress in non-native nucleic acid modifications
McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300
Ma, W., Yang, Y., Zhu, J., Jia, W., Zhang, T., Liu, Z., Chen, X., & Lin, Y. (2022) · Advanced Materials · doi:10.1002/adma.202109609 · Cited by 300
Metadata
- Authors
- Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., Bawab, A. A., & Ismail, S. I.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-12-18
- Volume
- 25
- Issue
- 1
- Pages
- 3
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2995953990
- Cited by
- 415
- References
- 251
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.